Troponin T in acute heart failure: Clinical implications and prognosis in the Spanish National Registry on Heart Failure

Abstract Background Elevated troponin in heart failure has been associated with worse prognosis, but there are differences in the design and results of published studies. Our objective was to determine the association of troponin T with mortality and readmissions in patients with acute heart failure in clinical practice conditions. Methods We included patients from the RICA registry who were hospitalized for acute heart failure. They were classified into 3 groups according to troponin T levels: normal, intermediate and high (< 0.02, 0.02–0.049 and ≥ 0.05 ng/mL, respectively). Survival was studied by Kaplan–Meier curves and the association of variables was tested by Cox regression analysis. Results A total of 406 patients was included. Average age was 76.9 (76.0–77.7) years. Hypertensive heart disease was the most common etiology. Left ventricular ejection fraction was < 45% in 22.1% of the patients. The group with elevated troponin T had higher proportions of women, systolic dysfunction, renal failure and anemia, a lower body mass index and longer hospital stay. At one year, patients with elevated troponin T had higher mortality than patients with normal troponin (35.5 vs. 13.9%, p < 0.001). The composite event (mortality and readmissions) was also more frequent (51.6 vs. 30.9%, p < 0.001), but there were no differences in readmissions alone. Troponin T ≥ 0.02 ng/mL was independently associated with mortality. Conclusions Elevated troponin T levels are common in patients with heart failure in clinical practice and are associated with increased mortality and events after one year of follow-up.